Antibody-drug conjugates (ADCs) have transformed breast cancer therapy but bring notable toxicity risks. This review examines the clinical evidence, adverse event management, and future directions for optimizing ADC use.
Once-weekly lonapegsomatropin (Skytrofa) is now FDA-approved for adult growth hormone deficiency, offering a more convenient alternative to daily injections with demonstrated efficacy and safety.
Emerging evidence links subclinical primary aldosteronism to significantly increased cardiovascular risk, even in normotensive individuals, highlighting the need for refined screening and personalized hypertension management.
Audit reveals major misclassification in hospital coding for myocardial infarction types, risking flawed epidemiology, reimbursement, and patient care.
A 12-week randomized trial finds that increasing daily sit-to-stand transitions reduces diastolic blood pressure in sedentary, overweight, or obese postmenopausal women but does not significantly affect glucose regulation.
Explore the methodology and significance of the 2025-2026 U.S. News Best Hospitals rankings, featuring top-performing hospitals nationwide and the criteria driving their recognition.
Emerging research reveals that prenatal exposure to fine particulate air pollution (PM2.5) may significantly increase a child’s risk of developing obesity, spotlighting pregnancy as a critical window for future health.
A groundbreaking trial highlights how hybrid closed-loop systems improve glycemic control for pregnant women with type 1 diabetes, offering enhanced maternal and fetal health outcomes.
Exploring groundbreaking FDA approvals in women's health, including new treatments for UTIs, at-home STI and cervical cancer tests, and AI-driven fetal anomaly detection.
Recent research highlights that estrogen-only hormone therapy may reduce breast cancer risk in women under 55, while combined estrogen-progestin therapy could increase risk.
A study reveals that complications during pregnancy, such as preeclampsia, gestational diabetes, and preterm birth, are linked to an increased risk of stroke years later.
Emerging research reveals heightened risk of cervical cancer in women aged 65 and older, driven by human papillomavirus (HPV). Continued screening is crucial to address increasing incidence and improve outcomes.
A large Danish study reveals that pro-inflammatory diets during pregnancy may increase the risk of type 1 diabetes in offspring, emphasizing the importance of maternal nutrition.
A clinical study reveals that trimethoprim-sulfamethoxazole does not significantly improve infant birth weight or related outcomes in HIV-positive pregnancies.